Scott Wieland

2015

In 2015, Scott Wieland earned a total compensation of $634.3K as Senior Vice President – Drug Development at CytRx, a 33% decrease compared to previous year.

Compensation breakdown

Bonus$75,000
Option Awards$159,300
Salary$400,000
Total$634,300
63.06%

Wieland received $400K in salary, accounting for 63% of the total pay in 2015.

Wieland also received $75K in bonus and $159.3K in option awards.

Rankings

In 2015, Scott Wieland's compensation ranked 9,909th out of 13,638 executives tracked by ExecPay. In other words, Wieland earned more than 27.3% of executives.

ClassificationRankingPercentile
All
9,909
out of 13,638
27th
Division
Manufacturing
3,786
out of 5,190
27th
Major group
Chemicals And Allied Products
1,382
out of 1,854
26th
Industry group
Drugs
1,133
out of 1,528
26th
Industry
Biological Products, Except Diagnostic Substances
193
out of 254
24th
Source: SEC filing on May 20, 2016.

Wieland's colleagues

We found four more compensation records of executives who worked with Scott Wieland at CytRx in 2015.

2015

Steven Kriegsman

CytRx

Chief Executive Officer

2015

Daniel Levitt

CytRx

Chief Medical Officer

2015

John Caloz

CytRx

Chief Financial Officer

2015

Benjamin Levin

CytRx

General Counsel

You may also like